News

Manel Esteller opens the First International Conference on Biology of Catalonia

The First International Conference of Biology of Catalonia joins more than eight hundred scientists from around the world The First International Conference on Biology of Catalonia, entitled “Global advanced questions on Biology,” will be opened with the conference “Epigenètica: de la biologia a la malaltia” by Manel Esteller, researcher at the Bellvitge Biomedical Research Institute […]

Leer más about Manel Esteller opens the First International Conference on Biology of Catalonia

Alliance to develop new personalized treatments against lung cancer

The Bellvitge Biomedical Research Institute (IDIBELL) has participated in the “Cancer of lungs: the molecular knowledge to treatment” international meeting co-organized with the Centre for Applied Medical Research (CIMA), from the University of Navarra. This event, framed within the Curelung project funded by the European Commission, brought international experts who presented the latest scientific and […]

Leer más about Alliance to develop new personalized treatments against lung cancer

Jaume Reventós: “We need to learn how dogs find cancer by the smell”

Jaume Reventós, PhD, from VHIR, gave a lecture at the hall of the Hospital Duran i Reynals (ICO) on last 29th June. He questioned the current diagnostic tests for prostate cancer and he talked about the kit he is developing to prevent up to 34% of current biopsies. He also spoke of the study about […]

Leer más about Jaume Reventós: “We need to learn how dogs find cancer by the smell”

Six students will live the summer in IDIBELL

Six students will have the opportunity to complete their formation in one of the IDIBELL research groups. The training will last three months, from July to September. The students have finished the last course of a biomedical bachelor’s program. The Scientific Direction of IDIBELL has evaluated the applications received and has announced the awarded of […]

Leer más about Six students will live the summer in IDIBELL

F. Xavier Bosch, Lilly Foundation for Biomedical Research award 2012

Delivery of the Lilly Foundation for Biomedical Research award 2012 F. Xavier Bosch, researcher at IDIBELL/ICO and world leader in human papilloma virus and cervical cancer, has received the Lilly Foundation for Biomedical Research award 2012 in the preclinical research category. Dr. Felipe Casanueva, scientific director of CIBERobn, who has contributed to international understanding of […]

Leer más about F. Xavier Bosch, Lilly Foundation for Biomedical Research award 2012

Manel Esteller receives a Merck Serono Research grant

Dr. Manel Esteller, from the Bellvitge Biomedical Research Institute (IDIBELL), has received a Merck Serono Research grant in the research area in molecular basis of rare diseases and their clinical implications for the project “Epigenetic characterization of Sotos Syndrome. Evaluation of the pharmacological treatments use aimed at enhancing the expression of microRNAs”. After 20 years, […]

Leer más about Manel Esteller receives a Merck Serono Research grant

The Ramon Areces Foundation funds UB and IDIBELL research projects

A project of Dr. Esteban Ballestar, from IDIBELL, funded by the Ramón Areces Foundation The Ramon Areces Foundation funded several research projects of UB and IDIBELL, through the Sixteenth Call of the Spanish National Competition. The act of delivery of the aid took place last June 27th at the headquarters of this organization in Madrid, […]

Leer más about The Ramon Areces Foundation funds UB and IDIBELL research projects

Bacterial translocation in cirrhotic patients: relationship with renal insufficiency and prognosis

IDIBELL Seminars. June 15, 2012. At the conference Dr José Such, from the Liver Unit of the General University Hospital of Alicante and CIBERehd, and specialized in bacterial translocation in cirrhotic patients, spoke of translocation and clinical effects. “The cirrhosis causes portal hypertension, which can lead to splanchnic vasodilation, all of which can cause the […]

Leer más about Bacterial translocation in cirrhotic patients: relationship with renal insufficiency and prognosis

Bellvitge researchers develop new method to reduce length of stay for patients with pneumonia

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have found a new safe and effective method to reduce the duration of intravenous antibiotic therapy and the length of hospital stay for patients with community-acquired pneumonia. This strategy would help to optimize the care of hospitalized patients with pneumonia and reduce the hospital costs. In Europe, […]

Leer más about Bellvitge researchers develop new method to reduce length of stay for patients with pneumonia
Scroll to Top